We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

106 hedge funds and large institutions have $368M invested in GenMark Diagnostics, Inc in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 28

42% more capital invested

Capital invested by funds: $259M → $368M (+$110M)

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

3% more funds holding

Funds holding: 103 → 106 (+3)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $74K

Holders
106
Holders Change
+3
Holders Change %
+2.91%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
41
Reduced
28
Closed
11
Calls
–
Puts
$74K
Net Calls
-$74K
Net Calls Change
-$15K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.76M
2
BG
Bellevue Group
Switzerland
+$2.33M
3
Goldman Sachs
Goldman Sachs
New York
+$1.88M
4
OAM
Oxford Asset Management
United Kingdom
+$1.66M
5
HighTower Advisors
HighTower Advisors
Illinois
+$1.48M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$9.69M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.93M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.39M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.98M
5
CC
Casdin Capital
New York
-$2.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
WI
51
WrapManager Inc
California
$378K -$28.3K -4,293 -7%
Ameriprise
52
Ameriprise
Minnesota
$369K -$403K -61,189 -54%
EGM
53
Engineers Gate Manager
New York
$369K +$343K +52,033 New
BCM
54
Bridgeway Capital Management
Texas
$354K -$856K -130,000 -72%
MFIM
55
Mesirow Financial Investment Management
Illinois
$344K +$103K +15,572 +47%
Squarepoint
56
Squarepoint
New York
$341K +$317K +48,094 New
Baird Financial Group
57
Baird Financial Group
Wisconsin
$335K – – –
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$329K – – –
CSS
59
Cubist Systematic Strategies
Connecticut
$328K +$305K +46,277 New
CS
60
Credit Suisse
Switzerland
$324K +$87.7K +13,314 +41%
LOAMU
61
Lombard Odier Asset Management (USA)
New York
$304K – – –
UBS AM
62
UBS AM
Illinois
$301K -$132K -20,053 -32%
PP
63
PDT Partners
New York
$255K -$61.9K -9,400 -21%
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$248K +$6.08K +924 +3%
ONB
65
Old National Bancorp
Indiana
$247K -$89.9K -13,656 -28%
AIG
66
American International Group
New York
$234K -$7.06K -1,072 -3%
SIM
67
Spark Investment Management
New York
$215K +$200K +30,418 New
SI
68
Stephens Inc
Arkansas
$210K +$103K +15,614 +112%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$188K – – –
MIM
70
MetLife Investment Management
New Jersey
$187K – – –
Invesco
71
Invesco
Georgia
$185K +$9.7K +1,473 +6%
CCIA
72
Campbell & Co Investment Adviser
Maryland
$181K +$65.1K +9,882 +63%
JG
73
Jefferies Group
New York
$154K -$21.2K -3,212 -13%
PCMI
74
Paradigm Capital Management Inc
New York
$140K – – –
VOYA Investment Management
75
VOYA Investment Management
Georgia
$140K – – –
1 2
3
4 5

GNMK Hedge Fund Activity: Q1 2019 in Review

106 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2019, worth a combined $368M — up 42% from $259M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new GNMK positions and 11 closed out — a net gain of 3 holders — while 41 added to existing stakes and 28 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.76M. The largest seller was JP Morgan Chase, cutting an estimated $9.69M.

  • 106 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2019, up from 103 in Q4 2018.
  • Funds reported $368M of GenMark Diagnostics, Inc stock for Q1 2019, up 42% quarter-over-quarter.
  • 14 funds opened new GenMark Diagnostics, Inc positions in Q1 2019 and 11 closed out, a net change of +3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q1 2019 was Millennium Management, an estimated $2.76M added.
  • The largest GenMark Diagnostics, Inc seller in Q1 2019 was JP Morgan Chase, an estimated $9.69M sold.

Based on aggregated 13F filings for Q1 2019.